Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (331-340 of 448) with videos related to

Pageof 45
Sort By:
Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.
Journal of Scleroderma and Related Disorders|May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Rheumatology (Oxford, England)|May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR databaseMichele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Annals of the Rheumatic Diseases|February 18, 2015
Digital ulcers predict a worse disease course in patients with systemic sclerosisCarina Mihai, Robert Landewé, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Arthritis Research & Therapy|February 20, 2020
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosisEmmanuel Ledoult, David Launay, Hélène Béhal, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
International Journal of Rheumatic Diseases|November 7, 2018
Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosisJun Won Park, Ga Young Ahn, Ji-Won Kim, et al.
Pageof 45

Showing results (331-340 of 448) with videos related to

Sort By:
Pageof 45
Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.
Journal of Scleroderma and Related Disorders|May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Rheumatology (Oxford, England)|May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR databaseMichele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Annals of the Rheumatic Diseases|February 18, 2015
Digital ulcers predict a worse disease course in patients with systemic sclerosisCarina Mihai, Robert Landewé, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Arthritis Research & Therapy|February 20, 2020
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosisEmmanuel Ledoult, David Launay, Hélène Béhal, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
International Journal of Rheumatic Diseases|November 7, 2018
Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosisJun Won Park, Ga Young Ahn, Ji-Won Kim, et al.
Pageof 45